People with cystic fibrosis who develop diabetes are taking part in a study to test technology that could ease daily care.
Insulet Stock: why GLP-1 fears are overblown, with growth driven by Europe/MENA expansion. Read here for a detailed analysis ...
Type 1 diabetes has shifted from a condition once associated with early mortality to a chronic disease owing to the ...
A Hybrid Machine Learning Framework for Early Diabetes Prediction in Sierra Leone Using Feature Selection and Soft-Voting Ensemble ...
WAN CHAI, WAN CHAI, HONG KONG, January 23, 2026 /EINPresswire.com/ -- Even with the advancement of Automated Insulin ...
In combining the precision of the twiist insulin delivery system with the unmatched longevity of Eversense 365, Sequel and Senseonics are enhancing diabetes management by offering more tools to manage ...
Insulet stock is up on fourth-quarter results ahead of consensus, with company leaders talking about talent, technology, and ...
IRVINE, Calif., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial ...
The X logo appears on a smartphone screen. (Photo by Nikolas Kokovlis/NurPhoto via Getty Images) (NurPhoto via Getty Images) When X's engineering team published the code that powers the platform's ...
The Trump administration announced that the company, a pharmacy benefit manager, had agreed to make significant changes to its practices. By Rebecca Robbins and Reed Abelson The reporters have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results